Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
Chromium(51Cr) edetate
CHROMIUM(51CR) EDETATE INJECTION CJ13P PATIENT INFORMATION LEAFLET IDENTIFICATION OF THE MEDICINAL PRODUCT N AME OF THE M EDICINAL P RODUCT Chromium(51Cr) edetate Injection Q UALITATIVE C OMPOSITION - Active ingredient : Chromium [ 51 Cr] edetate - Other ingredients : Disodium EDTA Ph.Eur. Benzyl alcohol Ph.Eur. Water for Injections Ph.Eur Q UANTITATIVE C OMPOSITION Each vial contains 6.4 mg and 37 MBq (Megabecquerel - the unit in which radioactivity is measured) of chromium [ 51 Cr] edetate. P HARMACEUTICAL F ORM Solution for injection P HARMACO -T HERAPEUTIC G ROUP Chromium [ 51 Cr] EDTA is a radiopharmaceutical product which is used to help to make a diagnosis. When injected, a radiopharmaceutical_ _ circulates in the bloodstream and may temporarily collect in some organs of the body. Because the substance contains a small amount of radioactivity it can be detected from outside the body using special cameras. Blood and urine samples can be collected and measured for radioactivity. This can give the physician valuable information about the functioning of particular organs N N AME AND A DDRESS OF THE M ANUFACTURER AND H OLDER OF THE M ARKETING A UTHORISATION GE Healthcare Limited Amersham Place Little Chalfont Buckinghamshire HP7 9NA United Kingdom WHEN IS THE PRODUCT USED ? After being injected into a vein, the rate of removal of chromium [ 51 Cr] EDTA from your body can be determined. This is normally done by measuring the amount in blood or urine samples. This rate can give your physician valuable information about the functioning of your kidneys. WARNINGS W HEN SHOULD THIS P RODUCT NOT BE USED Olvassa el a teljes dokumentumot